Recently, a heat-shock-like transcription factor
TBF1 was identified as the major molecular switch during growth-to-defense transition in Arabidopsis thaliana.
- August 1, 2019) - Canntab Therapeutics (CSE: PILL) (OTCQX: CTABF) (FSE:
TBF1), a leading innovator in hard pill oral dose therapeutic cannabinoid and terpene blends, has updated investors about significant developments.
Recently, we identified a novel plant transcription factor
TBF1 that acts as a major molecular switch for the growth-to-defense transition.